← Eichor
Study identifier: NCT06874296 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Assessing Declined Liver Grafts With Normothermic Machine Perfusion to Reduce Transplant Waiting Time

Condition: Liver Transplantation · Liver Diseases · Surgery  ·  Sponsor: Charite University, Berlin, Germany

PhaseNA
Planned participants186
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The goal of this study is to find out if quality assessment by normothermic machine perfusion can be used to safely increase the number of usable donor livers, helping more people get transplants faster and with better results. This process keeps a donated liver working outside the body before transplantation, allowing surgeons to assess whether livers previously considered unsuitable can still be used. The main questions this study aims to answer are: * Does this method help patients get a transplant sooner? * Can this method make more livers available for transplant? * Does it improve survival and health after transplant? Participants in this study must be on the waiting list for a liver transplant with a ReMELD-Na-Score of 21 or less (equivalent to MELD ≤25) and must not qualify for certain special exceptions. Participants will be randomly placed into one of two groups: * Experimental group: In addition to regular organ offers, these participants may receive a liver that was initially not considered for transplantation but meets quality standards after at least four hours of machine perfusion. * Control group: These participants will receive a liver through the usual transplant process. The main measure of success is how quickly participants receive a transplant. Researchers will also look at other important factors, such as survival rates, quality of life, hospital stay, and complications after transplant. This study may help improve liver transplantation by making …

This description comes directly from the study's public registry record.

Talk to the study team

Nathanael Raschzok, MD  ·  +49 30 450 552 001  ·  nathanael.raschzok@charite.de

Simon Moosburner, MD  ·  +49 30 450 552 595  ·  simon.moosburner@charite.de

Always discuss trial participation with your own doctor first.

Locations (10)

University Medical Center Hamburg-EppendorfHamburg, Free and Hanseatic City of Hamburg, GermanyRecruiting
University Hospital RWTH AachenAachen, North Rhine-Westphalia, GermanyRecruiting
University Hospital BonnBonn, North Rhine-Westphalia, GermanyRecruiting
University Hospital MuensterMünster, North Rhine-Westphalia, GermanyRecruiting
Department of Surgery Campus Charité Mitte | Campus Virchow-Klinikum, Charité - Universitätsmedizin BerlinBerlin, State of Berlin, GermanyRecruiting
Department of General, Visceral and Transplant Surgery, Hannover Medical SchoolHanover, GermanyRecruiting
Department of General, Visceral and Transplantation Surgery, LMU University Hospital, LMU MunichMünchen, GermanyRecruiting
Department of Surgery, University Hospital RegensburgRegensburg, GermanyRecruiting
Eberhard Karls University of Tübingen, Department of General Visceral and Transplant SurgeryTübingen, GermanyRecruiting
Department of General, Visceral, Transplantation, Vascular, and Pediatric Surgery, University Hospital WurzburgWürzburg, GermanyRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06874296